POSTER: ALL-589 Post Hoc Analysis of MRD Negativity After End of Induction in the Phase 3 PhALLCON Trial
Year: 2025
Type: article
Authors: Ibrahim Aldoss, Pankit Vachhani, Hagop Kantarjian, Pau Montesinos, Jessica Leonard, David Gomez-Almaguer, Maria R. Baer, Carlo Gambacorti-Passerini, James McCloskey, Yosuke Minami, Cristina Papayannidis, Vanderson Rocha, Philippe Rousselot, Eunice Wang, Meliessa Hennessy, Alexander Vorog, Niti Patel, Jose-Maria Ribera Santasusana, Elias Jabbour
Institutions: City Of Hope National Medical Center, City of Hope, University of Alabama at Birmingham, The University of Texas MD Anderson Cancer Center, Hospital Universitari i Politècnic La Fe, Oregon Health & Science University, Universidad Autónoma de Nuevo León, Hospital Universitario Dr José Eleuterio Gonzalez, University of Maryland, Baltimore, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Milano-Bicocca, Hackensack University Medical Center, National Cancer Center Hospital East, Istituto di Ematologia di Bologna, Universidade de São Paulo, Instituto do Câncer do Estado de São Paulo, Université de Versailles Saint-Quentin-en-Yvelines, Roswell Park Comprehensive Cancer Center, Hospital Universitari Germans Trias i Pujol
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413813134